Morgan Stanley Starts Onyx Pharmaceuticals (ONXX) at Underweight
ONXX Hot Sheet
Rating Summary:10 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Morgan Stanley initiates coverage on Onyx Pharmaceuticals (NASDAQ: ONXX) with a Underweight. PT $38.00.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $42.45 yesterday, with a 52 week range of $27.17-$46.07.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $42.45 yesterday, with a 52 week range of $27.17-$46.07.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Bernstein Starts Onyx Pharmaceuticals (ONXX) at Outperform
- Canaccord Genuity Maintains a 'Hold' on Tiffany & Co. (TIF); Cutting PT and Estimates
- Oppenheimer Starts Callidus Software (CALD) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
